Historic Resolution by WHO to Address Hemophilia and Bleeding Disorders Globally

WHO's Historic Decision on Hemophilia

On February 3, 2026, a monumental step was taken by the Executive Board of the World Health Organization (WHO) when it approved a resolution titled "Global Action to Advance Health Equity for People with Hemophilia and Other Bleeding Disorders." This resolution is a turning point for health equity initiatives aimed at individuals suffering from hemophilia and other coagulation disorders.

The resolution, which was driven by member states, is set to be presented at the upcoming 79th World Health Assembly in May 2026 for final adoption. The World Federation of Hemophilia (WFH), an important non-state actor with official relations to the WHO, championed this resolution and has expressed unwavering support for its successful adoption.

Understanding Hemophilia and Bleeding Disorders

Hemophilia is a genetic condition where blood does not clot properly, leading to prolonged bleeding. Individuals with this disorder may experience spontaneous bleeding episodes, especially in joints and muscles, potentially resulting in long-term development and mobility issues. It is crucial to recognize these complications, as they significantly affect the quality of life and health outcomes for those impacted.

Commitment to Health Equity

This resolution signifies more than just a policy document; it illustrates a commitment by the WHO and its member states to prioritize coagulation disorders within the global health agenda. By adopting this resolution, the global health community aims to create a coordinated framework to tackle health inequities that severely affect individuals with these conditions.

Supporting this initiative, the WFH has initiated a global call for health equity regarding bleeding disorders. This movement underscores the urgent need for better resources, training, and care for those affected, aiming to unite various stakeholders—including governments, health care professionals, and patient advocacy groups.

The Role of the World Federation of Hemophilia

Founded in 1963, the WFH is a non-profit organization dedicated to improving care and treatment for people with inherited bleeding disorders worldwide. The federation collaborates with national member organizations and health care professionals to enhance knowledge and provide critical support for individuals with these conditions. Through partnerships with governments and hemophilia treatment centers, the WFH focuses on education, advocacy, and the provision of necessary tools and resources for care.

As the approved resolution advances towards implementation, it is expected to encourage countries to develop specific strategies tailored to their unique contexts in addressing the challenges faced by those with hemophilia and other bleeding disorders.

Next Steps

The WHO’s upcoming 79th World Health Assembly will be pivotal as global health leaders gather to discuss and finalize the adoption of this resolution. This presents an opportunity to galvanize resources and action towards achieving equitable health outcomes for people living with hemophilia and coagulation disorders. The support from the global health community and organizations like the WFH will be key in driving the changes outlined in the resolution.

By collectively acknowledging the often-overlooked issues related to hemophilia and other bleeding disorders, the world takes an essential step forward in addressing health inequities and ensuring that affected individuals receive the care and support they deserve.

For more information about the WFH and to follow their initiatives, please visit www.wfh.org.